$0.3398
-0.0016-0.47%
Last update: Dec 15, 9:25 AM
Comments
Loading...
Co-Diagnostics Stock Guidance | NASDAQ:CODX | Benzinga
Co-Diagnostics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
FAQ
What is the most recent guidance for Co-Diagnostics (CODX)?
The most recent guidance for Co-Diagnostics (CODX) was reported on March 24, 2022 for Q1 2022. The company provided earnings per share guidance in the range of $0.17 to $0.20, compared to the estimated EPS of $0.11. Additionally, Co-Diagnostics forecasted revenue between $0.02B and $0.02B for the quarter.
Browse guidance and forecast on all stocks.
